TrialLeukemia & lymphoma2011

High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas.

Douglas E Gladstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.